Toxicology: Past, present, and future

Annals of Clinical and Laboratory Science

Volumn 29, Issue 4, 1999, Pages 253-262

  Pappas, Alex A ^a   Massoll, Nicole A ^a   Cannon, Donald J ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; BENZOYLECGONINE; CANNABIS; CANNABIS DERIVATIVE; COCAINE; COCAINE DERIVATIVE; METHAMPHETAMINE; MORPHINE; OPIATE; OPIATE DERIVATIVE; PHENCYCLIDINE;

ANALYTICAL EQUIPMENT; ANALYTICAL PARAMETERS; ARTICLE; CLINICAL FEATURE; DRUG SCREENING; ENVIRONMENTAL HEALTH; EXPERIMENTATION; FORENSIC MEDICINE; HISTORY OF MEDICINE; INDUSTRIAL MEDICINE; OCCUPATIONAL MEDICINE; PHARMACEUTICS; PRIORITY JOURNAL; TOXICOLOGY; WORKPLACE;

ENVIRONMENTAL MEDICINE; FORENSIC MEDICINE; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, ANCIENT; OCCUPATIONAL MEDICINE; TOXICOLOGY;

CANNABIS;

EID: 0032728173     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. DuBois KP. Textbook of toxicology. New York: Oxford University Press 1959.
2. Niyogi SK. Historical overview of forensic toxicology. In: Cravey RH, Baselt RC, editors. Introduction to forensic toxicology. Biomedical Publications 1981:7-21.
3. Clarke EGC. Isolation and identification of drugs in pharmaceuticals, body fluids, and post-mortem material. Volume I, II. The Pharmaceutical Press, London 1978.
4. Methodology for analytical toxicology. In: I Sunshine, editor. CRC Press, Cleveland, OH 1975.
5. Pappas AA, Taylor EH, Ackerman B. Toxicology and drugs of abuse. In: Howanitz JH, Howanitz PJ, editors. Laboratory medicine: Test selection and interpretation. New York: Churchill Livingstone 1991:369-398.
6. Council on Scientific Affairs. Scientific issues in drug testing. JAMA 1987;257/22:3110-3114.
7. McBay AJ. Drug-analysis technology-pitfalls and problems of drug testing. Clin Chem 1987;33(11 Suppl):33B-40B.
8. Levine BS, Smith ML, Froede RC. Postmortem forensic toxicology. Clinics in Laboratory Medicine, Clinical Toxicology II. WB Saunders, Philadelphia, PA 1990;10/3:571-590.
9. Wallace JE, Hamilton UE. Analytical principles. In: Cravey RH, Baselt RC, editors. Introduction to forensic toxicology. Biomedical Publications 1981:87-109.
10. Ellenhorn M, Schonwald S, Ordog G, Wasserberger J. Ellenhorn medical toxicology. In: Cooke DB, Zinner SR, editors. Williams & Wilkins, Baltimore 1997;13-46:1912-1925.
11. Pappus AA, Taylor EH, Ackerman B. Therapeutic drug monitoring. In: Howanitz JH, Howanitz PJ, editors. Laboratory medicine: test selection and interpretation. New York: Churchill Livingstone 1991:333-368.
12. McBay AJ. Toxicological findings in fatal poisonings. Clin Chem 1973;19/4:361-365.
13. Baselt RC. Disposition of toxic drugs in man. Year Book Medical Publishers, Chicago, 4th edition 1995
14. Litovitz T, Manoguerra A. Comparison of pediatric poisoning hazards: An analysis of 3.8 million exposure incidents. A report from the american association of poison control centers. Pediatrics 1992;89(6 pt 1): 999-1006.
15. Pappas AA, Gadsden RH Sr, Taylor EH. Serum osmolality in acute intoxication: A prospective clinical study. Am J Clin Pathol 1985;85/1:74-79.
16. Liang HK. Clinical evaluation of the poisoned patient and toxic syndromes. Clin Chem 1996;42/8:1350-1355.
17. Bayer MJ, McKay C. Advances in poison management. Clin Chem 1996;42/8:1361-1366.
18. DuBois KP, Geiling EMK. Alcohols and other industrial solvents. In: DuBois KP, Geiling EMK, eds. Textbook of toxicology. New York: Oxford University Press 1959:3-17.
19. Irving J. Drug testing in the military-technical and legal problems. Clin Chem 1988;34/3:637-640.
20. Finkle BS. Drug-analysis technology: Overview and state of the art. Clin Chem 1987;32(11 suppl):13B-17B.
21. Snyder JW, Klees JE. Drug testing programs in government agencies and private workplaces. Occup Med 1996;11/1:87-101.
22. Critical issues in urinalysis of abused substances report of the substance abuse committee. Clin Chem 1988;34/3:605-632.
23. Osterloh J. Drug testing in the workplace. Occup Med 1990;5/3:617-633.
24. Christophersen AS, Morland J. Drug analysis for control purposes in forensic toxicology, workplace testing, sports medicine, work and related areas. Pharmcol Toxicol 1994;74/4-5:202-210.
25. Issac PC, Heatley M, Savoie J. Rates of drug detection in urine samples from various populations. Clin in Lab Med 1990;10/2:289-299.
26. Jones DW, Adams D, Martel PA, Rousseau RJ. Drug population in one thousand geographically distributed urine specimens. J Anal Toxicol 1985;9/3:125-130.
27. Rouse, BA. Epidemiology of illicit and abused drugs in the general population, emergency department drug-related episodes, and arrestees. Clin Chem 1996;42/8:1330-1336.
28. Lundberg GD. Mandatory unindicated urine drug screening: Still chemical McCarthyism. JAMA 1986; 256/21:3003-3005.
29. Dougherty RJ. Controversies regarding urine testing J Subst Abuse Treat 1987;4/2:115-117.
30. Dupont RL, Griffin DW, Siskin BR, Shiraki S, Katze E. Random Drug Tests at Work: The probability of identifying frequent and infrequent users of illicit drugs. J Addict Dis 1995;14/3:1-17.
31. Peat MA. Financial viability of screening for drugs of abuse. Clin Chem 1994;41/5:805-808.
32. Http://www.osha.gov
33. Vemitt S. Occupational cancer, biological mechanisms. In: Raffle PB, Adams PII. Baxter PH, Lee WR, editors. Hunter's diseases of occupations, 8th ed. London: Edward Arnold Publishers 1994:623-653.
34. Harring JM, Saracci R. Occupational cancer, clinical and epidemiological aspects. In: Raffle PB, Adams PII. Baxter PH, Lee WR, editors. Hunter's diseases of occupations, 8th ed. London: Edward Arnold Publishers 1994;7/22:654-688.
35. International Agency for Research. Evaluation of carcinogenic risk to humans, international agency for research on cancer. In: Raffle PB. Adams PH, Baxter PH, Lee WR, editors. Hunter's diseases of occupations, 8th ed. London: Edward Arnold Publishers 1994:743-748.
36. Http://www.iarc.fr/
37. Ward EM, Burnett CA, Ruder A, Davis-King K. Industries and cancer. Cancer causes control 1997; 8/3:356-370.
38. Zbinden G. Three eras of research in experimental toxicology. TiPS 1992;13:221-223.
39. Kramer PJ. Genetic Toxicology. J Pharm Pharmacol 1998;50/4:395-405.
40. White PA. The genotoxic hazards of domestic wastes in surface waters. Mutation Research 1998;410:223-236.
41. Silkworth JB, Brown JF. Evaluating the impact of exposure to environmental contaminants on human health. Clin Chem 1996;42/8:1345-1349.
42. Council on Scientific Affairs. Cancer risk of pesticides in agricultural workers. JAMA 1988:260:959-966.
43. Http://wvw.epa.gov
44. Dich J, Zahm SH, Hanberg A, Adami HO. Pesticides and cancer. Cancer Causes Control 1997;8/3:420-443.
45. Chenoweth MB. Perspectives in toxicology. Ann Rev Pharmacol Toxicol 1985;25:3.3-40
46. Ames BN, Gold LS. The causes and prevention of cancer: the role of environment. Biotherapy 1998;11/2-3:205-220.
47. Grandjean P. Biomarkers in epidemiology. Clin Chem 1995;41/12B:1800-1803.
48. Cullen MR, Redlich CA. Significance of individual sensitivity to chemicals; elucidation of host susceptibility by use of biomarkers in environmental health research. Clin Chem 1995;41(12B):1809-1813.
49. Chamberlain RT. Role of the clinical toxicologist in court. Clin Chem 1996;42(8 pt 2):1337-1341.
50. Rodricks JV, Hieth SII. Toxicological risk assessment in the courtroom: are available methodologies suitable for evaluating toxic tort and product liability claims? Regal Toxicol Pharmacol 1998;27(1 Pt 1):21-31.
51. Lundberg GD. New winds blowing for american drug policies. JAMA 1997;278/11:946-947.